Metin Kurtoglu - Chief Technology Officer at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technology Officer
Stock Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Metin Kurtoglu since 9/17/2023

Holdings reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51K $74.5K $1.46 Apr 8, 2024 Direct
Stock Option (Right to Buy) 14.3K $11.3K $0.79 Apr 8, 2024 Direct Common Stock

Transactions reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.